China commits to healthcare reforms
This article was originally published in Clinica
China has announced that it will be releasing details of its healthcare reforms in the near future. But the areas that will be prioritised are: state-run hospitals, which are to be upgraded, and new facilities built; purchase of “big medical apparatus”; funding for “key academic research” and for doctor training; and funding for healthcare provision for the elderly. Hospitals to be given priority status in terms of government support will be those providing care related to epidemic conditions, vocational illnesses, and conditions related to maternity and affecting children; and basic public health services such as disease prevention, inoculation and health education.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.